WATCH: Exploring Cutting-Edge Research in Integrative Oncology with Dr. Donald Abrams
In this engaging discussion, Dr. Mary Hardy and Dr. Donald Abrams review new research presented at the 2025 American Society of Clinical Oncology (ASCO) meeting, highlighting how integrative approaches can improve quality of life, reduce side effects, and support better cancer outcomes. They share clinical insights, lively commentary, and practical takeaways for people living with cancer.
. First published on : Aug 26 2025Ivermectin and Cancer: A Closer Look At Its Use and Risks
Ivermectin, a drug used routinely to treat parasitic worm infections, has gained massive popularity online and interest from some oncologists. While it is a generally safe drug, taken at high doses there are risks. In this article we’ll discuss the research for ivermectin as a cancer therapy, and the gaps in research to support anecdotal success stories.
. First published on : Aug 13 2025Repurposed Drugs in Cancer Care
With widespread access to cancer research studies and anecdotal stories through internet searches and social media, people with cancer are becoming increasingly proactive in exploring all available treatment options. This trend has spurred grassroots adoption of complex supplement regimens and repurposed drug protocols. The fact that there is some evidence for various repurposed drugs to improve cancer outcomes makes it tempting for individuals to assume these drugs will help their cancer.
. First published on : Jan 28 2025Fenbendazole and Cancer: A Closer Look at Its Use and Risks
CancerChoices reviews and synthesizes the evidence behind complementary therapies including repurposed drugs. Given the significant interest in our review of Mebendazole and Fenbendazole, and our accompanying article on repurposed drugs, we’ve partnered with Mark Taylor of Patient Led Oncology to provide a deeper analysis of Fenbendazole.
. Last modified on : May 30 2025Three Surprisingly Effective Complementary Cancer Therapies: Aspirin, Vitamin D, and Melatonin
In this CancerChoices webinar, Michael Lerner, Nancy Hepp, and Laura Pole, MSN, RN, OCNS of CancerChoices explore the good evidence of effectiveness for improving survival and reducing risk of cancer for three complementary therapies.
. First published on : Jan 02 2025New Efforts to Make Cell Therapies Like CAR-T More Accessible for Patients
Cell therapies like CAR-T are an extraordinary new class of drugs that have the potential to successfully treat cancer.
. Last modified on : Jan 25 2025Lindsay McDonell: What’s Next? Living with Metastatic Breast Cancer
Five years into living with recurrence, I’m more focused on asking ‘What’s the next thing?’ and researching therapies put before me to figure out if they are likely to help me.
. Last modified on : Dec 27 2023